Quote For GlaxoSmithKline PLC GSK.L
sector: Healthcare ·
industry: Pharmaceuticals - Diversified ·
As of
9 Feb 2010
1,218.50GBp
1,218.50p
9 Feb 2010
-0.04%
1,219.00p
1,218.50p
12,797,801
1,227.00p
1,212.50p
1,347.00p
982.00p
0.44
14,159,429
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Gent, Christopher |
Non-Executive Chairman of the Board |
651,000 |
| Witty, Andrew |
Chief Executive Officer, Executive Director |
1,778,000 |
| Heslop, Julian |
Chief Financial Officer, Executive Director |
926,000 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
£63,282.04 |
| Shares Outstanding (Mil.) |
5,191.31 |
| Float (Mil.) |
5,178.84 |
| |
| Dividend Information |
| Yield % |
-- |
| Annual Dividend (£ GBP) |
0.61 |
| Payout Ratio(TTM) % |
55.87 |
| |
| Financial Strength |
| Quick Ratio |
1.11 |
| Current Ratio |
1.45 |
| LT Debt/Equity |
147.79 |
| Total Debt/Equity |
162.49 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
11.25 |
| Price/Sales(TTM) |
2.23 |
| Price/Book(TTM) |
6.33 |
| Price/Cash Flow(TTM) |
9.12 |
| |
|
| Per Share Data |
| Earnings(TTM) |
£1.09 |
| Sales(TTM) |
£5.56 |
| Book Value(MRQ) |
£1.93 |
| Cash Flow(TTM) |
£1.36 |
| Cash(MRQ) |
£1.31 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
61.67 |
| Return on Assets(TTM) |
13.78 |
| Return on Investment(TTM) |
19.22 |
| |
|
| Margins |
| Gross Margin(TTM) % |
73.98 |
| Operating Margin(TTM) % |
29.69 |
| Profit Margin(TTM) % |
19.98 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives